UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Annals of oncology, 2022-06, Vol.33 (6), p.602-615

2022

Link zum Volltext

Verfügbarkeit prüfen

Auto-SCT in severe paraproteinemic neuropathy

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.457-459

2011

Link zum Volltext

Verfügbarkeit prüfen

155TiP Phase II study of tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTE®) immuno-oncology therapy targeting DLL3, in third-line or later small cell lung cancer (SCLC)

Annals of oncology, 2022-04, Vol.33, p.S103-S104

2022

Link zum Volltext

Verfügbarkeit prüfen

1383P Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study

Annals of oncology, 2023-10, Vol.34, p.S793-S794

2023

Link zum Volltext

Verfügbarkeit prüfen

508MO Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study

Annals of oncology, 2023-11, Vol.34, p.S1664-S1665

2023

Link zum Volltext

Verfügbarkeit prüfen

LBA92 Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study

Annals of oncology, 2023-10, Vol.34, p.S1333-S1334

2023

Link zum Volltext

Verfügbarkeit prüfen

1329P FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered NSCLC

Annals of oncology, 2023-10, Vol.34, p.S767-S767

2023

Link zum Volltext

Verfügbarkeit prüfen

1325P Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)

Annals of oncology, 2021-09, Vol.32, p.S1015-S1016

2021

Link zum Volltext

Verfügbarkeit prüfen

OA12.05 Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S33

2022

Link zum Volltext

Verfügbarkeit prüfen

48MO Phase I study of AMG 757, a delta-like ligand 3 (DLL3) targeting, half-life extended bispecific T-cell engager immuno-oncology therapy, in small cell lung cancer (SCLC)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S720-S721

2021

Link zum Volltext

Verfügbarkeit prüfen

214TiP Tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer (LS-SCLC): DeLLphi-306 (NCT06117774)

ESMO open, 2024-03, Vol.9, p.102787, Article 102787

2024

Link zum Volltext

Verfügbarkeit prüfen

195MO Tarlatamab in previously treated small cell lung cancer (SCLC): DeLLphi-300 phase I study long-term outcomes and intracranial activity

ESMO open, 2024-03, Vol.9, p.102768, Article 102768

2024

Link zum Volltext

Verfügbarkeit prüfen

147P Characterizing CRS in phase I study of DLL3-targeted T cell engager tarlatamab in small cell lung cancer

Immuno-oncology technology, 2022-12, Vol.16, p.100259, Article 100259

2022

Link zum Volltext

Verfügbarkeit prüfen

Confusion Regarding the Anatomy of the Superficial Inferior Epigastric Artery and the Superficial Circumflex Iliac Artery Superficial Branch

Plastic and reconstructive surgery. Global open, 2024-04, Vol.12 (4), p.e5714-e5714

2024

Link zum Volltext

Verfügbarkeit prüfen

Auto-SCT in severe paraproteinemic neuropathy

Bone marrow transplantation, 2011, Vol.46 (3), p.457-459

2011

Link zum Volltext

Verfügbarkeit prüfen

NIC. H. RIDDERBOS, "Die Psalmen: Stilistische Verfahren und Aufbau mit besonderer Berücksichtigungn von Ps 1-41" (Book Review)

Catholic Biblical Quarterly, 1973, Vol.35 (3), p.403

Hummel, H D

1973

Link zum Volltext

Verfügbarkeit prüfen

JOSEPH REINDL, "Das Angesicht Gottes im Sprachgebrauch des Alten Testaments" (Book Review)

Catholic Biblical Quarterly, 1972, Vol.34 (2), p.242

Hummel, H D

1972

Link zum Volltext

Verfügbarkeit prüfen

JÖRG JEREMIAS, "Kultprophetie und Gerichtsverkündigung in der späten Königszeit Israels" (Book Review)

Catholic Biblical Quarterly, 1971, Vol.33 (4), p.589

Hummel, H D

1971

Link zum Volltext

Verfügbarkeit prüfen

DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control

Nature genetics, 2015-11, Vol.47 (11), p.1316-1325

2015

Link zum Volltext

Verfügbarkeit prüfen

Stellar parameters of Be stars observed with X-shooter

Astronomy and astrophysics (Berlin), 2018-01, Vol.609, p.A108

2018

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription

Blood, 2000-02, Vol.95 (4), p.1443-1450

2000

Link zum Volltext

Verfügbarkeit prüfen

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis

Neuro-oncology (Charlottesville, Va.), 2012-06, Vol.14 (6), p.790-797

2012

Link zum Volltext

Verfügbarkeit prüfen

Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue

Gut, 2001-12, Vol.49 (6), p.804-812

2001

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription

Blood, 2001-01, Vol.97 (2), p.496-501

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(93)
Japanisch
(11)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(56)
Humans
(53)
Biological And Medical Sciences
(35)
Medical Sciences
(33)
Male
(29)
Female
(28)
Middle Aged
(27)
Adult
(19)
Hematologic And Hematopoietic Diseases
(17)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(16)
Aged
(15)
Adolescent
(13)
In Situ Hybridization
(12)
Hematology
(11)
Oncology
(11)
Pathology
(11)
Child
(10)
Hodgkin Disease - Pathology
(9)
Immunohistochemistry
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Auto-SCT in severe paraproteinemic neuropathy

155TiP Phase II study of tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTE®) immuno-oncology therapy targeting DLL3, in third-line or later small cell lung cancer (SCLC)

1383P Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study

508MO Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study

LBA92 Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study

1329P FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered NSCLC

1325P Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)

OA12.05 Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer

48MO Phase I study of AMG 757, a delta-like ligand 3 (DLL3) targeting, half-life extended bispecific T-cell engager immuno-oncology therapy, in small cell lung cancer (SCLC)

214TiP Tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer (LS-SCLC): DeLLphi-306 (NCT06117774)

195MO Tarlatamab in previously treated small cell lung cancer (SCLC): DeLLphi-300 phase I study long-term outcomes and intracranial activity

147P Characterizing CRS in phase I study of DLL3-targeted T cell engager tarlatamab in small cell lung cancer

Confusion Regarding the Anatomy of the Superficial Inferior Epigastric Artery and the Superficial Circumflex Iliac Artery Superficial Branch

Auto-SCT in severe paraproteinemic neuropathy

NIC. H. RIDDERBOS, "Die Psalmen: Stilistische Verfahren und Aufbau mit besonderer Berücksichtigungn von Ps 1-41" (Book Review)

JOSEPH REINDL, "Das Angesicht Gottes im Sprachgebrauch des Alten Testaments" (Book Review)

JÖRG JEREMIAS, "Kultprophetie und Gerichtsverkündigung in der späten Königszeit Israels" (Book Review)

DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control

Stellar parameters of Be stars observed with X-shooter

Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut Allergy Study

Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis

Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue

Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription

Suchergebnisse filtern